Adverse events and patients' perceived health-related quality of life at the end of multidrug-resistant tuberculosis treatment in Namibia.

Sagwa, Evans L; Ruswa, Nunurai; Mavhunga, Farai; Rennie, Timothy; Leufkens, Hubert Gm; Mantel-Teeuwisse, Aukje K.

Afiliação

Sagwa EL; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.
Ruswa N; National Tuberculosis and Leprosy Program, Ministry of Health and Social Services, Windhoek, Namibia.
Mavhunga F; National Tuberculosis and Leprosy Program, Ministry of Health and Social Services, Windhoek, Namibia.
Rennie T; Department of Pharmacy Practice and Policy, University of Namibia School of Pharmacy, Windhoek, Namibia.
Leufkens HG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands; Medicines Evaluation Board, Utrecht, the Netherlands.
Mantel-Teeuwisse AK; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.

Patient Prefer Adherence ; 10: 2369-2377, 2016.

Article em En | MEDLINE | ID: mdl-27920503